CD11b+CD43hiLy6Clo splenocyte‐derived macrophages exacerbate liver fibrosis via spleen‐liver axis
Shaoying Zhang,Dan Wan,Mengchen Zhu,Guihu Wang,Xurui Zhang,Na Huang,Jian Zhang,Chongyu Zhang,Qi Shang,Chen Zhang,Xi Liu,Fanfan Liang,Chunyan Zhang,Guangyao Kong,Jing Geng,Libo Yao,Shemin Lu,Yongyan Chen,Zongfang Li
DOI: https://doi.org/10.1002/hep.32782
IF: 17.298
2022-09-14
Hepatology
Abstract:Background & aims Monocyte‐derived macrophages (MoMFs), a dominant population of hepatic macrophages under inflammation, play a crucial role in liver fibrosis progression. Spleen serves as an extra monocyte reservoir in inflammatory conditions; however, the precise mechanisms of involvement of spleen in the pathogenesis of liver fibrosis remain unclear. Approach & results By splenectomy and splenocyte transfusion, it was observed that splenic CD11b+ cells accumulated intrahepatically as Ly6Clo MoMFs to exacerbate CCl4‐induced liver fibrosis. The splenocyte migration into the fibrotic liver was further directly visualized by spleen‐specific photo‐convertion with KikGR mice and confirmed by CD45.1+/CD45.2+ spleen transplantation. Spleen‐derived CD11b+ cells purified from fibrotic livers were then annotated by scRNA‐seq and a subtype of CD11b+CD43hiLy6Clo splenic monocytes (sM‐1s) was identified, which was markedly expanded in both spleens and livers of mice with liver fibrosis. sM‐1s exhibited mature feature with high expressions of F4/80, produced much ROS, and manifested preferential migration into livers. Once recruited, sM‐1s underwent sequential transformation to sM‐2s (highly expressed Mif, Msr1, Clec4d, and Cstb), and then to sMφs with macrophage features of higher expressions of CX3CR1, F4/80, MHC II and CD64 in the fibrotic hepatic milieu. Further, sM‐2s and sMφs were demonstrated capable of activating hepatic stellate cells and thus exacerbating liver fibrosis. Conclusions CD11b+CD43hiLy6Clo splenic monocytes migrate into liver and shift to macrophages, which account for the exacerbation of liver fibrosis. These findings reveal precise mechanisms of spleen‐liver axis in hepatic pathogeneisis, and shed light on the potential of sM‐1 as candidate target for controlling liver diseases.
gastroenterology & hepatology